The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures The Washington Post FDA Peptide Reclassification 2026: What It Means for Providers